$185.08 meals Payment -- Teva Pharmaceuticals to Dr. Charles Baker
Teva Pharmaceuticals provided a $185 meal to a Texas-based psychiatrist in relation to Revlimid.
This page provides a detailed analysis of a $185.08 meals payment from Teva Pharmaceuticals to Dr. Charles Baker. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $185.08 |
| Payment Type | meals |
| Payment Nature | Food and Beverage |
| Pharmaceutical Company | Teva Pharmaceuticals |
| Physician | Dr. Charles Baker |
| NPI Number | 1225193601 |
| Physician Specialty | Psychiatry |
| Location | Austin, TX |
| Date of Payment | 2025-01-06 |
| Related Drug/Device | Revlimid |
| Conflict Assessment | Low -- Routine |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Teva Pharmaceuticals made a $185.08 meals payment to Charles Baker, a Psychiatry specialist in Austin, TX. The payment was associated with Revlimid. This record details a $185.08 meal payment made by Teva Pharmaceuticals to Dr. Charles Baker, a psychiatrist in Austin, TX. The payment was associated with Revlimid, a drug used to treat multiple myeloma and other conditions. The payment occurred on January 6, 2025, and is categorized as 'Food and Beverage'.
Patient Guidance: What This Payment Means for You
If you are a patient being treated with Revlimid, understand that your doctor may receive meals from the pharmaceutical company that manufactures it. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
For psychiatrists, meals and beverages are a common form of payment from pharmaceutical companies, often related to specific drugs like Revlimid.
Regulatory Context: Sunshine Act Requirements
Payments made by pharmaceutical companies to physicians, including meals, must be reported under the Sunshine Act to ensure transparency in healthcare.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-compensation
- meals-and-entertainment
- tevapharmaceuticals
- psychiatry
- revlimid
Understanding meals Payments
Food and beverage payments cover meals provided to physicians during pharmaceutical sales representative visits, medical conferences, and educational events. While individual meal payments tend to be small (often under $100), research published in JAMA Internal Medicine has shown that even modest meals can be associated with changes in prescribing behavior. Meal payments are the most common type of pharmaceutical payment to physicians.
Frequently Asked Questions About This Payment
What was this $185.08 payment for?
This was a meals payment of $185.08 from Teva Pharmaceuticals to Charles Baker, categorized as "Food and Beverage". It was associated with Revlimid. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Charles Baker accept pharmaceutical money?
Yes, Charles Baker received this $185.08 payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Charles Baker's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this meals payment?
A meals payment of $185.08 is generally routine and common in the industry. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Psychiatry?
To compare this payment against Psychiatry averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Psychiatry physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Charles Baker's relationship with Teva Pharmaceuticals?
The payment amount is relatively small, suggesting a meal rather than a significant educational event. This $185.08 meals payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Psychiatry?
The specific drug, Revlimid, is a significant therapy, making the context of the meal potentially relevant to its use.
What should patients do after learning about this payment?
If you are a patient being treated with Revlimid, understand that your doctor may receive meals from the pharmaceutical company that manufactures it.
What else should I know about this meals payment?
The payment date is in the future, indicating this is a pre-scheduled or reported event.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.